Key Highlights

● Anthropic's IPO roadshow was expected to start the week of November 9.

● It filed its S-1 on October 26 and Amendment No. 1 on November 2.

● It plans to list on the Nasdaq under the ticker ANT.

● Its filing cites about $895 billion of AI infrastructure commitments through 2045.

A roadshow is the stretch before an initial public offering when a company and its bankers pitch the deal to big investors, gauging Demand before setting a price. For Anthropic, that process was expected to start the week of Monday, November 9, 2026.

The paperwork is in place. Anthropic filed its S-1 registration statement on October 26 and Amendment No. 1 on November 2, and plans to list on the Nasdaq Global Select Market under the ticker "ANT," according to the filings as reported. A syndicate of 22 underwriters is led by Goldman Sachs (NYSE:GS) and Morgan Stanley (NYSE:MS).

Why investors are fixated

The scale is what grabs attention. Anthropic's filing cites roughly $895 billion of AI infrastructure commitments through 2045 and third-quarter Revenue of $17.0 billion. The Financial Times has reported a fundraising target of $80 billion to $100 billion, which would make it an unusually large offering.

The timing is delicate. The deal comes just after the post-midterm AI sell-off that pushed the Nasdaq Composite into correction territory on November 5, reports said. Reported valuation talk has cooled from earlier levels as a result, with reports of a range of $1.2 trillion to $1.3 trillion on November 6.

No price range or share count was on file as of Monday, reports said. The Information has reported that a listing could come the week of November 16, though that timing has not been confirmed.

The market mood helps

Monday's market offered a friendlier backdrop. The S&P 500 jumped 173.08 points to 7,549.94, its best day since April 8, and the Nasdaq Composite surged 673.71 points to 25,253.14. Chip stocks led, with Advanced Micro Devices (NASDAQ:AMD) soaring. Goldman Sachs helped lead the Dow, and Morgan Stanley shares climbed as well.

A Truist strategist described the sentiment shift: "The mood is changing from a fear of downside to the fear of missing out on the upside." That kind of mood tends to help big offerings. The Cboe Volatility Index, a gauge of expected swings in the S&P 500, sank back below 20 on Monday, another sign that the turbulence of the prior week had eased, at least for now.

The broader IPO market has been subdued while investors wait. Renaissance Capital ran a headline noting a "Quiet start for the 4Q IPO market as Anthropic looms."

A test for the AI trade

Anthropic's debut is likely to be read as a referendum on how much public investors are willing to pay for AI developers rather than the chipmakers that Supply them. Its large infrastructure commitments also tie it to the spending debate: Goldman Sachs sees AI capex growth peaking, and a research firm has warned that spending has outpaced operating cash flow, according to market reports.

Other AI listings are in the spotlight, too. Cerebras faces a lock-up expiry alongside its third-quarter results on November 12, according to market data.

Listing Date and Demand Signals

The key items are the price range and share count, which would appear in an amended filing. Investors will also watch for reporting on demand from big institutions during the roadshow and for confirmation of a listing date. Market conditions matter: Tuesday's October consumer price index, this week's results from CoreWeave, Nebius, Cisco and Applied Materials, and Nvidia's November 17 report could all sway sentiment toward AI just as Anthropic tries to set its price.